Eric Monticello's profile photo

Eric Monticello

Featured in: Favicon csl.com Favicon agrinews-pubs.com

Articles

  • Aug 22, 2024 | agrinews-pubs.com | Eric Miller |Eric Monticello

    It continues to look fantastic. We just got through one of the coolest and wettest Julys on record for Illinois, so that’s a good combination for crops. Our weather station had about seven and a quarter inches of rain for July. Boy, does that make double-crop soybeans look good. They have never looked better. They are just fantastic this year. They have a long way to go, but they have a great start and I would say they have never looked better at this time of the year.

  • Mar 20, 2024 | csl.com | Eric Monticello

    Enlarged lymph nodes are a symptom of the rare condition, Castleman disease, but swollen lymph nodes are also a symptom of many other conditions. And that’s one reason it’s difficult to diagnose Castleman disease, said Michael Gonzalez, Ph.D. and Director of Basic and Translational Research at University of Pennsylvania’s Perelman School of Medicine. The condition caused by a hyperactive immune system can damage organs or even be fatal.

  • Mar 7, 2024 | csl.com | Eric Monticello

    Alfredo Álvarez, a project manager with CSL Vifor in Gijón, Spain, is helping create and execute a vision for how Patient Blood Management (PBM) can be implemented in health care. PBM acknowledges the risks of anemia, blood loss and bleeding disorders. As the World Health Organization describes, it’s “a systematic, multidisciplinary, multiprofessional concept to routinely minimize for these risk factors,” which places the patient at the center of care.

  • Feb 21, 2024 | csl.com | Eric Monticello

    As vaccination rates fall in the United States, leaders at the U.S. Food and Drug Administration (FDA) are calling upon doctors, pharmacists and others in the clinical and biomedical community to educate the public “in plain language” about the health benefits of vaccines.

  • Feb 14, 2024 | csl.com | Eric Monticello

    Patients wait eagerly for new treatments, but it takes years to fully investigate, conceive of and test a new medicine. The National Organization for Rare Disorders (NORD), which advocates for rare disease patients, recently launched a new course that helps explain the process.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →